[28C2-am] Structure-activity relationship/Drug design/Structure-activity relationship

Tue. Mar 28, 2023 11:00 AM - 12:00 PM [Room C2] Institute for the Advancement of Higher Education: S5 (Bldg. S: 1F)

Chair: Aya Tanatani, Ayato Sato

+Add all to schedule

11:00 AM - 11:12 AM

[28C2-am11S] Synthesis of carboranes as hypoxia-inducible factor-1 signaling inhibitors

○YUJIE SHAO¹, Yasunobu Asawa¹, Kazuki Miura^1,2, Taiki Morita^1,2, Hiroyuki Nakamura^1,2 (1. Sch. Life Sci. Tech., Tokyo Tech., 2. CLS., Tokyo Tech. )

11:12 AM - 11:24 AM

[28C2-am12S] A human serum albumin-binding helix-loop-helix peptide tag for prolonged activity of biopharmaceuticals

○Yuto Nakatani¹, Zhengmao Ye³, Yuki Ishizue⁴, Taishi Higashi⁴, Teruko Imai^4,5, Ikuhiko Nakase^1,2, Ikuo Fujii^1,2, Masataka Michigami^1,2 (1. Grad. Sch. Sci., Osaka Prefecture Univ., 2. Grad. Sch. Sci., Osaka Metropolitan Univ., 3. Interprotein Corp., 4. Grad. Sch. Pharm. Sci., Kumamoto Univ., 5. Daiichi Univ. Pharm.)

11:24 AM - 11:36 AM

[28C2-am13S] Development of novel compounds inducing cancer cell death selective under low-pH conditions based on salinazid

○Saki Hatsuzawa¹, Ryosuke Ishida¹, Hiroyuki Kagechika¹ (1. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University)

11:36 AM - 11:48 AM

[28C2-am14] Development of middle molecule drug based on phytic acid (IP6)

○takuya masunaga¹, Tsugumasa Toma¹, Yuichi Arakaki¹, Nobukazu Miyakawa², Mikio Todaka³, Tatsuya Kondo², Eiichi Araki², Mikako Fujita¹, Masami Otsuka^1,4, Hiroshi Tateishi¹ (1. Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Science, Kumamoto University, 2. Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, 3. Todaka Clinic, 4. Science Farm Ltd.)

11:48 AM - 12:00 PM

[28C2-am15] Development of an anti-diabetes drug candidate that suppresses lipid accumulation

○Hiroshi Tateishi¹, Tsugumasa Toma¹, Yuiichi Aragaki¹, Nobukazu Miyakawa², Mikio Todaka³, Tatsuya Kondo², Eiichi Araki², Masami Otsuka^1,4, Mikako Fujita¹ (1. Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, 2. Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, 3. Todaka Clinic, 4. Science Farm Ltd)

Session information